Melovem

国家: 欧盟

语言: 英文

来源: EMA (European Medicines Agency)

现在购买

资料单张 资料单张 (PIL)
19-06-2014
产品特点 产品特点 (SPC)
19-06-2014
公众评估报告 公众评估报告 (PAR)
10-10-2013

有效成分:

meloxicam

可用日期:

Dopharma Research B.V.

ATC代码:

QM01AC06

INN(国际名称):

meloxicam

治疗组:

Pigs; Calves

治疗领域:

Oxicams

疗效迹象:

CattleFor use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle. For use in diarrhoea in combination with oral rehydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle. For adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.PigsFor use in noninfectious locomotor disorders to reduce the symptoms of lameness and inflammation. For the relief of postoperative pain associated with minor soft-tissue surgery such as castration. For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.HorsesFor use in the alleviation of inflammation and relief of pain in both acute and chronic musculoskeletal disorders. For the relief of pain associated with equine colic.

產品總結:

Revision: 5

授权状态:

Authorised

授权日期:

2009-07-07

资料单张

                                35
B. PACKAGE LEAFLET
36
PACKAGE LEAFLET FOR:
Melovem 5 mg/ml solution for injection for cattle and pigs
1.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF
THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH
RELEASE, IF DIFFERENT
Marketing authorisation holder:
Dopharma Research B.V.
Zalmweg 24
4941 VX Raamsdonksveer The Netherlands
Manufacturer responsible for batch release:
Dopharma B.V.
Zalmweg 24
4941 VX Raamsdonksveer The Netherlands
2.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Melovem 5 mg/ml solution for injection for cattle and pigs
Meloxicam
3.
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)
Each ml contains:
ACTIVE SUBSTANCE:
Meloxicam 5 mg
EXCIPIENT(S):
Benzyl alcohol 50 mg
A clear, greenish yellow solution.
4.
INDICATION(S)
CATTLE:
For use in acute respiratory infection with appropriate antibiotic
therapy to reduce clinical signs in
cattle.
For use in diarrhoea in combination with oral re-hydration therapy to
reduce clinical signs in calves of
over one week of age and young, non-lactating cattle.
For the relief of post-operative pain following dehorning in calves.
PIGS:
For use in non-infectious locomotor disorders to reduce the symptoms
of lameness and inflammation.
For the relief of post operative pain associated with minor soft
tissue surgery such as castration.
5.
CONTRAINDICATIONS
Do not use in animals suffering from impaired hepatic, cardiac or
renal function and haemorrhagic
disorders, or where there is evidence of ulcerogenic gastrointestinal
lesions.
37
Do not use in case of hypersensitivity to the active substance or to
any of the excipients.
For the treatment of diarrhoea in cattle, do not use in animals of
less than one week of age.
Do not use in pigs less than 2 days old.
6.
ADVERSE REACTIONS
Transient swelling at the injection site was commonly reported in
clinical studies following
subcutaneous administration in cattle. Injection site swelling may be
painful.
Transient swelling at the injection site was observed in clinical
studies following intramuscu
                                
                                阅读完整的文件
                                
                            

产品特点

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Melovem 5 mg/ml solution for injection for cattle and pigs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Meloxicam 5 mg
EXCIPIENT(S):
Benzyl alcohol 50 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear, greenish yellow solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle (calves and young cattle) and pigs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Cattle:
For use in acute respiratory infection with appropriate antibiotic
therapy to reduce clinical signs in
cattle.
For use in diarrhoea in combination with oral re-hydration therapy to
reduce clinical signs in calves of
over one week of age and young, non-lactating cattle.
For the relief of post-operative pain following dehorning in calves.
Pigs:
For use in non-infectious locomotor disorders to reduce the symptoms
of lameness and inflammation.
For the relief of post operative pain associated with minor soft
tissue surgery such as castration.
4.3
CONTRAINDICATIONS
Do not use in animals suffering from impaired hepatic, cardiac or
renal function and haemorrhagic
disorders, or where there is evidence of ulcerogenic gastrointestinal
lesions.
Do not use in case of hypersensitivity to the active substance or to
any of the excipients.
For the treatment of diarrhoea in cattle, do not use in animals of
less than one week of age.
Do not use in pigs less than 2 days old.
3
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Treatment of calves with Melovem 20 minutes before dehorning reduces
post-operative pain.
Melovem alone will not provide adequate pain relief during the
dehorning procedure. To obtain
adequate pain relief during surgery co-medication with an appropriate
analgesic is needed.
Treatment of piglets with Melovem before castration reduces post
operative pain. To obtain pain relief
during surgery co-medication with an appropriate anaesthetic/sedative
is needed.
To obtain the
                                
                                阅读完整的文件
                                
                            

其他语言的文件

资料单张 资料单张 保加利亚文 19-06-2014
产品特点 产品特点 保加利亚文 19-06-2014
公众评估报告 公众评估报告 保加利亚文 10-10-2013
资料单张 资料单张 西班牙文 19-06-2014
产品特点 产品特点 西班牙文 19-06-2014
公众评估报告 公众评估报告 西班牙文 10-10-2013
资料单张 资料单张 捷克文 19-06-2014
产品特点 产品特点 捷克文 19-06-2014
公众评估报告 公众评估报告 捷克文 10-10-2013
资料单张 资料单张 丹麦文 19-06-2014
产品特点 产品特点 丹麦文 19-06-2014
公众评估报告 公众评估报告 丹麦文 10-10-2013
资料单张 资料单张 德文 19-06-2014
产品特点 产品特点 德文 19-06-2014
公众评估报告 公众评估报告 德文 10-10-2013
资料单张 资料单张 爱沙尼亚文 19-06-2014
产品特点 产品特点 爱沙尼亚文 19-06-2014
公众评估报告 公众评估报告 爱沙尼亚文 10-10-2013
资料单张 资料单张 希腊文 19-06-2014
产品特点 产品特点 希腊文 19-06-2014
公众评估报告 公众评估报告 希腊文 10-10-2013
资料单张 资料单张 法文 19-06-2014
产品特点 产品特点 法文 19-06-2014
公众评估报告 公众评估报告 法文 10-10-2013
资料单张 资料单张 意大利文 19-06-2014
产品特点 产品特点 意大利文 19-06-2014
公众评估报告 公众评估报告 意大利文 10-10-2013
资料单张 资料单张 拉脱维亚文 19-06-2014
产品特点 产品特点 拉脱维亚文 19-06-2014
公众评估报告 公众评估报告 拉脱维亚文 10-10-2013
资料单张 资料单张 立陶宛文 19-06-2014
产品特点 产品特点 立陶宛文 19-06-2014
公众评估报告 公众评估报告 立陶宛文 10-10-2013
资料单张 资料单张 匈牙利文 19-06-2014
产品特点 产品特点 匈牙利文 19-06-2014
公众评估报告 公众评估报告 匈牙利文 10-10-2013
资料单张 资料单张 马耳他文 19-06-2014
产品特点 产品特点 马耳他文 19-06-2014
公众评估报告 公众评估报告 马耳他文 10-10-2013
资料单张 资料单张 荷兰文 19-06-2014
产品特点 产品特点 荷兰文 19-06-2014
公众评估报告 公众评估报告 荷兰文 10-10-2013
资料单张 资料单张 波兰文 19-06-2014
产品特点 产品特点 波兰文 19-06-2014
公众评估报告 公众评估报告 波兰文 10-10-2013
资料单张 资料单张 葡萄牙文 19-06-2014
产品特点 产品特点 葡萄牙文 19-06-2014
公众评估报告 公众评估报告 葡萄牙文 10-10-2013
资料单张 资料单张 罗马尼亚文 19-06-2014
产品特点 产品特点 罗马尼亚文 19-06-2014
公众评估报告 公众评估报告 罗马尼亚文 10-10-2013
资料单张 资料单张 斯洛伐克文 19-06-2014
产品特点 产品特点 斯洛伐克文 19-06-2014
公众评估报告 公众评估报告 斯洛伐克文 10-10-2013
资料单张 资料单张 斯洛文尼亚文 19-06-2014
产品特点 产品特点 斯洛文尼亚文 19-06-2014
公众评估报告 公众评估报告 斯洛文尼亚文 10-10-2013
资料单张 资料单张 芬兰文 19-06-2014
产品特点 产品特点 芬兰文 19-06-2014
公众评估报告 公众评估报告 芬兰文 10-10-2013
资料单张 资料单张 瑞典文 19-06-2014
产品特点 产品特点 瑞典文 19-06-2014
公众评估报告 公众评估报告 瑞典文 10-10-2013
资料单张 资料单张 挪威文 19-06-2014
产品特点 产品特点 挪威文 19-06-2014
资料单张 资料单张 冰岛文 19-06-2014
产品特点 产品特点 冰岛文 19-06-2014
资料单张 资料单张 克罗地亚文 19-06-2014
产品特点 产品特点 克罗地亚文 19-06-2014
公众评估报告 公众评估报告 克罗地亚文 10-10-2013

搜索与此产品相关的警报

查看文件历史